Revaia: Investment Portfolio & Startup News
Revaia
To add a bio or update investment portfolio click update information.
Investment Portfolio


Semble
4 Jun 2026
Semble secures £30m Series C led by Revaia to expand its healthcare coordination platform for outpatient providers
Semble is a healthcare management platform for outpatient providers that connects and coordinates every stage of the patient journey. The platform integrates with over 1,200 external tools across diagnostics, billing, labs and CRM, serving solo clinicians, group practices and enterprise healthcare organisations.


Definely
9 Jun 2025
Definely raises £22m Series B led by Revaia to expand AI-powered contract review platform for legal teams
Definely builds AI-powered tools that integrate directly into Microsoft Word, helping legal teams navigate complex contracts by surfacing relevant information and improving speed and accuracy during drafting and review.
Revaia
- 1(12 months)
- revaia.com
More venture news
- 17 Nov 2026

Isomorphic LabsIsomorphic Labs unlocks a £3.8bn Series C round led by Greenoaks and Sequoia Capital to design new medicines with AI
Series CLife Sciences - 11 Nov 2026

FractileFractile raises a £540m Series C from investors including Thrive and Founders Fund to build the chips that AI frontiers run on
Series CDeep Tech - 15 Oct 2026

OMass TherapeuticsOMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform
Series CLife Sciences